Lassa fever resources
PPE washing and drying station Lassa ward Owo
ISARIC is committed to strengthening the evidence base for Lassa fever therapeutics and improving case management. We have initiated a number of activities to address these knowledge gaps, which are conducted alongside a wide-range of partners and collaborators.
Tile subhead - What is Lassa fever? Context and treatments.
Tile subhead - How can case management and treatment outcomes be improved?
Tile subhead - Analyses of current treatments for Lassa.
Tile subhead - Explore WALC's framework for Lassa fever treatment.
Visit this section to find ISARIC’s articles, studies and more.
Children hospitalised with Omicron did not have a higher risk of experiencing long-term health issues compared to other infections, finds latest study
8 February 2024: A new study finds that children hospitalised with initial COVID-19 variant showed more signs of dermatological, fatigue, gastrointestinal, sensory, and sleep issues, as well as behavioural and emotional problems.
18 December 2023: The International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) is working with partners to create a framework on endpoint selection for clinical trials for outbreak-prone infectious diseases. This call for a public consultation invites feedback on what the framework does well, what could be improved and the limits of its potential application.